Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Xolair (omalizumab), which is manufactured by Genentech, was approved by the FDA in 2003 for use among adults and children over the age of 12. The medication is prescribed to treat moderate to severe persistent asthma caused by airborne allergens (grass, pollen and dust).